{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:22Z","timestamp":1792686202373,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lanwpc.2025.101770","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:15:15Z","timestamp":1765340115000},"page":"101770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approach"],"prefix":"10.1016","volume":"65","author":[{"given":"Tze-Fan","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-8950","authenticated-orcid":false,"given":"Chu-Pak","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Keong","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngai-Yin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-2361","authenticated-orcid":false,"given":"Rungroj","family":"Krittayaphong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2025.101770_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused Update Consensus Guidelines of the Asia Pacific heart rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanwpc.2025.101770_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101770_bib3","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101770_bib4","first-page":"S14","article-title":"Silent atrial fibrillation as a stroke risk factor and anticoagulation indication","volume":"29","author":"Glotzer","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib6","doi-asserted-by":"crossref","first-page":"euae012","DOI":"10.1093\/europace\/euae012","article-title":"Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey-how are we dealing with controversial approaches?","volume":"26","author":"Guerra","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2024.01.002","article-title":"Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: what decision making on anticoagulation after the NOAH and ARTESiA trials?","volume":"123","author":"Boriani","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib9","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/eurheartj\/ehae365","article-title":"Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation","volume":"45","author":"Sanders","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101770_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101770_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circulation Cardiovascular quality and outcomes"},{"key":"10.1016\/j.lanwpc.2025.101770_bib14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.hrthm.2024.06.038","article-title":"Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: a pooled analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"21","author":"Huang","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101770_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","article-title":"Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT","volume":"9","author":"Kaufman","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101770_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101770_bib18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.lanwpc.2025.101770_bib19","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1016\/j.hrthm.2025.07.002","article-title":"Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"22","author":"Boriani","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101770_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101770_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lanwpc.2025.101770_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad272","article-title":"Asymptomatic atrial fibrillation among hospitalized patients: clinical correlates and in-hospital outcomes in improving care for cardiovascular disease in China-atrial fibrillation","volume":"25","author":"Lin","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib23","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib24","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2021.6128","article-title":"Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with Ischemic Stroke: the PER DIEM randomized clinical trial","volume":"325","author":"Buck","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.lanwpc.2025.101770_bib25","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.hrthm.2024.05.059","article-title":"Effect of implantable loop recorder-based continuous rhythm monitoring on incident atrial fibrillation and stroke: an updated systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Abideen Asad","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101770_bib26","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1161\/STROKEAHA.121.034777","article-title":"Atrial fibrillation detected after stroke and transient Ischemic attack: a novel clinical concept challenging current views","volume":"53","author":"Sposato","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.lanwpc.2025.101770_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00415-025-13056-6","article-title":"Analysis of prognostic differences and risk factors in patients with atrial fibrillation known before ischemic stroke and atrial fibrillation diagnosed after ischemic stroke","volume":"272","author":"Liu","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/23969873241300888","article-title":"Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection","volume":"10","author":"Alvarado-Bolanos","year":"2025","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.lanwpc.2025.101770_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(24)00475-7","article-title":"Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial","volume":"24","author":"Shoamanesh","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100967","article-title":"Comparing CHA(2)DS(2)-VA and CHA(2)DS(2)-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"Teppo","year":"2024","journal-title":"The Lancet regional health Europe"},{"key":"10.1016\/j.lanwpc.2025.101770_bib31","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1038\/s41467-024-51193-0","article-title":"Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort","volume":"15","author":"Nielsen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanwpc.2025.101770_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae280","article-title":"Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?","volume":"26","author":"Yoshimura","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib33","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.hrthm.2025.05.067","article-title":"Stroke risks in women vs men in Asian patients with atrial fibrillation: a temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores","volume":"22","author":"Cheng","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanwpc.2025.101770_bib34","article-title":"Temporal trends in ischemic stroke and female sex as a risk modifier in atrial fibrillation: insights from non-anticoagulated Asian patients in a nationwide cohort study","volume":"60","author":"Kang","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2025.101770_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2024.05.002","article-title":"Apixaban vs Aspirin according to CHA(2)DS(2)-VASc score in subclinical atrial fibrillation: insights from ARTESiA","volume":"84","author":"Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib36","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/eurheartj\/ehae596","article-title":"Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"45","author":"Schnabel","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101770_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/eurheartj\/ehad771","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes >\/=24 h","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanwpc.2025.101770_bib38","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2025.101770_bib39","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.amjcard.2023.08.017","article-title":"Chapter 3: evidence for the use of early rhythm control to prevent atrial fibrillation progression","volume":"205","author":"Deering","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/europace\/euad023","article-title":"Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial","volume":"25","author":"Blomstrom-Lundqvist","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacep.2019.12.013","article-title":"The atrium and embolic stroke: myopathy not atrial fibrillation as the requisite determinant?","volume":"6","author":"Sajeev","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.lanwpc.2025.101770_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae204","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.lanwpc.2025.101770_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101757","article-title":"Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF registry","volume":"55","author":"Romiti","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanwpc.2025.101770_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacasi.2023.04.008","article-title":"Integrated care for atrial fibrillation using the ABC pathway in the prospective APHRS-AF registry","volume":"3","author":"Bucci","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.lanwpc.2025.101770_bib45","article-title":"Adherence to the ABC (atrial fibrillation better care) pathway and risk of adverse outcomes in patients with chronic kidney disease: a report from the prospective APHRS-AF registry","volume":"58","author":"Bucci","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2025.101770_bib46","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41591-025-03511-2","article-title":"Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial","volume":"31","author":"Chu","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.lanwpc.2025.101770_bib47","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T21:07:04Z","timestamp":1767820024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606525003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S2666606525003098"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101770","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approach","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101770"}}